
Malgorzata A. Walicka
Examiner (ID: 315)
| Most Active Art Unit | 1652 |
| Art Unit(s) | 1652 |
| Total Applications | 345 |
| Issued Applications | 187 |
| Pending Applications | 28 |
| Abandoned Applications | 130 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 17784580
[patent_doc_number] => 11407692
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2022-08-09
[patent_title] => Method for oxidative cleavage of compounds with unsaturated double bond
[patent_app_type] => utility
[patent_app_number] => 16/860690
[patent_app_country] => US
[patent_app_date] => 2020-04-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 5066
[patent_no_of_claims] => 11
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 187
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16860690
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/860690 | Method for oxidative cleavage of compounds with unsaturated double bond | Apr 27, 2020 | Issued |
Array
(
[id] => 16221198
[patent_doc_number] => 20200246314
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-08-06
[patent_title] => DYSLIPIDEMIA THERAPEUTIC AGENT
[patent_app_type] => utility
[patent_app_number] => 16/853121
[patent_app_country] => US
[patent_app_date] => 2020-04-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 4352
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -13
[patent_words_short_claim] => 64
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16853121
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/853121 | DYSLIPIDEMIA THERAPEUTIC AGENT | Apr 19, 2020 | Abandoned |
Array
(
[id] => 16375030
[patent_doc_number] => 20200323872
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-10-15
[patent_title] => HETEROCYCLIC COMPOUNDS AS RSV INHIBITORS
[patent_app_type] => utility
[patent_app_number] => 16/842539
[patent_app_country] => US
[patent_app_date] => 2020-04-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 15564
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -18
[patent_words_short_claim] => 225
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16842539
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/842539 | Heterocyclic compounds as RSV inhibitors | Apr 6, 2020 | Issued |
Array
(
[id] => 17837639
[patent_doc_number] => 20220274944
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-09-01
[patent_title] => COMPOSITE ABSORBENT AND USE THEREOF
[patent_app_type] => utility
[patent_app_number] => 17/637241
[patent_app_country] => US
[patent_app_date] => 2020-03-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 9694
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -19
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17637241
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/637241 | COMPOSITE ABSORBENT AND USE THEREOF | Mar 22, 2020 | Pending |
Array
(
[id] => 17837639
[patent_doc_number] => 20220274944
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-09-01
[patent_title] => COMPOSITE ABSORBENT AND USE THEREOF
[patent_app_type] => utility
[patent_app_number] => 17/637241
[patent_app_country] => US
[patent_app_date] => 2020-03-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 9694
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -19
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17637241
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/637241 | COMPOSITE ABSORBENT AND USE THEREOF | Mar 22, 2020 | Pending |
Array
(
[id] => 17393353
[patent_doc_number] => 11242354
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2022-02-08
[patent_title] => 4-sulfur substituted podophyllotoxin derivative and preparation method therefor and use thereof
[patent_app_type] => utility
[patent_app_number] => 16/825251
[patent_app_country] => US
[patent_app_date] => 2020-03-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 3
[patent_no_of_words] => 9049
[patent_no_of_claims] => 14
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 21
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16825251
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/825251 | 4-sulfur substituted podophyllotoxin derivative and preparation method therefor and use thereof | Mar 19, 2020 | Issued |
Array
(
[id] => 16625192
[patent_doc_number] => 20210043845
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-02-11
[patent_title] => INERT SOLUTION-PROCESSABLE MOLECULAR CHROMOPHORES FOR ORGANIC ELECTRONIC DEVICES
[patent_app_type] => utility
[patent_app_number] => 16/823210
[patent_app_country] => US
[patent_app_date] => 2020-03-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 22062
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -19
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16823210
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/823210 | INERT SOLUTION-PROCESSABLE MOLECULAR CHROMOPHORES FOR ORGANIC ELECTRONIC DEVICES | Mar 17, 2020 | Abandoned |
Array
(
[id] => 16175405
[patent_doc_number] => 20200222373
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-07-16
[patent_title] => RIFABUTIN FOR THE TREATMENT OF ACINETOBACTER BAUMANNII
[patent_app_type] => utility
[patent_app_number] => 16/821861
[patent_app_country] => US
[patent_app_date] => 2020-03-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 15652
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -16
[patent_words_short_claim] => 14
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16821861
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/821861 | Rifabutin for the treatment of acinetobacter baumannii | Mar 16, 2020 | Issued |
Array
(
[id] => 17563106
[patent_doc_number] => 20220127255
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-04-28
[patent_title] => HERBICIDAL COMPOUNDS
[patent_app_type] => utility
[patent_app_number] => 17/435253
[patent_app_country] => US
[patent_app_date] => 2020-03-05
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 15160
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -19
[patent_words_short_claim] => 811
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17435253
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/435253 | HERBICIDAL COMPOUNDS | Mar 4, 2020 | Abandoned |
Array
(
[id] => 16268720
[patent_doc_number] => 20200270207
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-08-27
[patent_title] => DEOXYURIDINE TRIPHOSPHATASE INHIBITORS
[patent_app_type] => utility
[patent_app_number] => 16/806115
[patent_app_country] => US
[patent_app_date] => 2020-03-02
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 32822
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -19
[patent_words_short_claim] => 366
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16806115
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/806115 | Deoxyuridine triphosphatase inhibitors | Mar 1, 2020 | Issued |
Array
(
[id] => 16012449
[patent_doc_number] => 20200181067
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-06-11
[patent_title] => FLUORINATED AMIDE DERIVATIVES AND THEIR USES AS THERAPEUTIC AGENTS
[patent_app_type] => utility
[patent_app_number] => 16/788815
[patent_app_country] => US
[patent_app_date] => 2020-02-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 20376
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -19
[patent_words_short_claim] => 278
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16788815
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/788815 | FLUORINATED AMIDE DERIVATIVES AND THEIR USES AS THERAPEUTIC AGENTS | Feb 11, 2020 | Abandoned |
Array
(
[id] => 16206420
[patent_doc_number] => 20200239410
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-07-30
[patent_title] => ANTIOXIDANT INFLAMMATION MODULATORS: OLEANOLIC ACID DERIVATIVES WITH AMINO AND OTHER MODIFICATIONS AT C-17
[patent_app_type] => utility
[patent_app_number] => 16/786429
[patent_app_country] => US
[patent_app_date] => 2020-02-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 39340
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -16
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16786429
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/786429 | Antioxidant inflammation modulators: oleanolic acid derivatives with amino and other modifications at c-17 | Feb 9, 2020 | Issued |
Array
(
[id] => 17821459
[patent_doc_number] => 11426382
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2022-08-30
[patent_title] => Sulcardine salts
[patent_app_type] => utility
[patent_app_number] => 16/775142
[patent_app_country] => US
[patent_app_date] => 2020-01-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 42
[patent_figures_cnt] => 44
[patent_no_of_words] => 24193
[patent_no_of_claims] => 3
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 50
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16775142
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/775142 | Sulcardine salts | Jan 27, 2020 | Issued |
Array
(
[id] => 17221774
[patent_doc_number] => 11174264
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2021-11-16
[patent_title] => TYK2 inhibitors and uses thereof
[patent_app_type] => utility
[patent_app_number] => 16/750610
[patent_app_country] => US
[patent_app_date] => 2020-01-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 48387
[patent_no_of_claims] => 19
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 11
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16750610
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/750610 | TYK2 inhibitors and uses thereof | Jan 22, 2020 | Issued |
Array
(
[id] => 16832060
[patent_doc_number] => 11008300
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2021-05-18
[patent_title] => Triazole n-linked carbamoyl cyclohexyl acids as LPA antagonists
[patent_app_type] => utility
[patent_app_number] => 16/744303
[patent_app_country] => US
[patent_app_date] => 2020-01-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 56131
[patent_no_of_claims] => 24
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 309
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16744303
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/744303 | Triazole n-linked carbamoyl cyclohexyl acids as LPA antagonists | Jan 15, 2020 | Issued |
Array
(
[id] => 20271934
[patent_doc_number] => 12441703
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2025-10-14
[patent_title] => Carboxamides as modulators of sodium channels
[patent_app_type] => utility
[patent_app_number] => 17/421944
[patent_app_country] => US
[patent_app_date] => 2020-01-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 151338
[patent_no_of_claims] => 23
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 11
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17421944
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/421944 | Carboxamides as modulators of sodium channels | Jan 8, 2020 | Issued |
Array
(
[id] => 16506113
[patent_doc_number] => 20200385369
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-12-10
[patent_title] => NEW BENZIMIDAZOLES DERIVATIVES AS TEC KINASES FAMILY INHIBITORS
[patent_app_type] => utility
[patent_app_number] => 16/737725
[patent_app_country] => US
[patent_app_date] => 2020-01-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 25759
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -11
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16737725
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/737725 | NEW BENZIMIDAZOLES DERIVATIVES AS TEC KINASES FAMILY INHIBITORS | Jan 7, 2020 | Abandoned |
Array
(
[id] => 15866023
[patent_doc_number] => 20200140415
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-05-07
[patent_title] => Salt and Polymorph of Benzopyrimidinone Compound and Pharmaceutical Composition and Use Thereof
[patent_app_type] => utility
[patent_app_number] => 16/736300
[patent_app_country] => US
[patent_app_date] => 2020-01-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 7496
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -16
[patent_words_short_claim] => 19
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16736300
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/736300 | Salt and polymorph of benzopyrimidinone compound and pharmaceutical composition and use thereof | Jan 6, 2020 | Issued |
Array
(
[id] => 15861253
[patent_doc_number] => 20200138030
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-05-07
[patent_title] => SUBSTITUTED OXADIAZOLES FOR COMBATING PHYTOPATHOGENIC FUNGI
[patent_app_type] => utility
[patent_app_number] => 16/731250
[patent_app_country] => US
[patent_app_date] => 2019-12-31
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 36350
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -10
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16731250
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/731250 | SUBSTITUTED OXADIAZOLES FOR COMBATING PHYTOPATHOGENIC FUNGI | Dec 30, 2019 | Abandoned |
Array
(
[id] => 17922739
[patent_doc_number] => 11465972
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2022-10-11
[patent_title] => Inhibitors of oxidized low-density lipoprotein receptor 1 and methods of use thereof
[patent_app_type] => utility
[patent_app_number] => 16/721103
[patent_app_country] => US
[patent_app_date] => 2019-12-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 20
[patent_figures_cnt] => 21
[patent_no_of_words] => 16485
[patent_no_of_claims] => 11
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 33
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16721103
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/721103 | Inhibitors of oxidized low-density lipoprotein receptor 1 and methods of use thereof | Dec 18, 2019 | Issued |